2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Understanding the role of LRRK2 in Indian population

A. Kishore, M. Sturm, A. Sreelatha, S. Robert, S. Krishnan, M. Banerjee, O. Riess, P. Bauer, R. Kruger, T. Gasser, M. Sharma (Trivandrum, India)
Unusual facial synkinesia after Bell’s palsy: interactive Marin-Amat syndrome proven by surface electromyogram, successfully treated with low dose botulinum toxin A.

H. Mori (Kurashiki, Japan)
Unusual MRI findings of the syndrome of acute bilateral basal ganglia lesions in diabetic uremia with hyperglycemia associated dyskinesia

P.-Y. Chen, A. Gutfreund, K. Brockmann, I. Wurster, G. Eschweiler, F. Metzger, W. Maetzler, D. Berg (Taipei, Taiwan)
Update on the MDS-Sponsored Systematic Review On Clinical Rating Scales for Huntington’s Disease: motor, cognitive, functional ability and quality of life domains

T. Mestre, C. Sampaio, C. Goetz, P. Martinez-Martin, G. Stebbins (Ottawa, ON, Canada)
UPDRS benefit from dual frequency DBS fields sculpted by intentionally overlapped interleaving

Y. Fernandez, D. Caputo, D. Schneider, R. Dipaola, S. Danish, E. Hargreaves (New York, NY, USA)
UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients

S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)
Use of latent class analysis and growth mixture modeling to examine longitudinal neurocognitive trajectories in non-demented Parkinson’s disease

L. Brennan, K. Devlin, D. Mechanic-Hamilton, J. Rick, S. Xie, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment

D. Weintraub, J. Norton, D. Fredericks, B. Coate, C. Andersson, C. Ballard (Philadelphia, PA, USA)
Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy

M. Jecmenica Lukic, T. Pekmezovic, I. Petrovic, A. Tomic, M. Svetel, V. Kostic (Belgrade, Serbia)
Using an Objective Measure of Movement to Quantify Night Time Sleep

P. Farzanehfar, P. Churchward, M. Horne (Parkville, Australia)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z